Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 13 studies | 27% ± 10% | |
oligodendrocyte | 12 studies | 28% ± 11% | |
glutamatergic neuron | 8 studies | 42% ± 27% | |
astrocyte | 8 studies | 29% ± 12% | |
oligodendrocyte precursor cell | 7 studies | 27% ± 13% | |
GABAergic neuron | 7 studies | 37% ± 22% | |
neuron | 5 studies | 26% ± 12% | |
interneuron | 5 studies | 37% ± 23% | |
microglial cell | 5 studies | 24% ± 6% | |
epithelial cell | 5 studies | 29% ± 11% | |
fibroblast | 5 studies | 18% ± 4% | |
macrophage | 5 studies | 25% ± 6% | |
GABAergic interneuron | 3 studies | 21% ± 7% | |
retinal ganglion cell | 3 studies | 23% ± 8% | |
ciliated cell | 3 studies | 18% ± 2% | |
dendritic cell | 3 studies | 19% ± 2% | |
endothelial cell of lymphatic vessel | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 3245.05 | 21 / 21 | 100% | 19.03 | 504 / 504 |
esophagus | 100% | 2629.33 | 1445 / 1445 | 100% | 23.15 | 183 / 183 |
lung | 100% | 3014.29 | 578 / 578 | 100% | 23.59 | 1155 / 1155 |
uterus | 100% | 3796.24 | 170 / 170 | 100% | 25.32 | 459 / 459 |
breast | 100% | 3210.12 | 459 / 459 | 100% | 27.92 | 1117 / 1118 |
brain | 100% | 2664.97 | 2638 / 2642 | 100% | 25.70 | 705 / 705 |
prostate | 100% | 3463.19 | 245 / 245 | 100% | 19.41 | 501 / 502 |
ovary | 100% | 3779.47 | 180 / 180 | 100% | 18.27 | 429 / 430 |
thymus | 100% | 3585.45 | 653 / 653 | 100% | 26.09 | 603 / 605 |
intestine | 100% | 2898.00 | 966 / 966 | 99% | 17.82 | 524 / 527 |
stomach | 100% | 2144.79 | 359 / 359 | 99% | 18.19 | 284 / 286 |
adrenal gland | 100% | 2903.33 | 258 / 258 | 99% | 16.98 | 228 / 230 |
kidney | 100% | 2503.17 | 89 / 89 | 99% | 18.15 | 891 / 901 |
pancreas | 100% | 1394.17 | 327 / 328 | 99% | 19.53 | 176 / 178 |
skin | 100% | 3718.42 | 1809 / 1809 | 93% | 21.07 | 441 / 472 |
liver | 100% | 1540.26 | 226 / 226 | 91% | 10.10 | 371 / 406 |
adipose | 100% | 3088.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3258.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.07 | 29 / 29 |
muscle | 100% | 2475.95 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4635.92 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.09 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.17 | 1 / 1 |
heart | 99% | 2155.20 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 1715.60 | 784 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 64% | 7.47 | 51 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035666 | Biological process | TRIF-dependent toll-like receptor signaling pathway |
GO_0002755 | Biological process | MyD88-dependent toll-like receptor signaling pathway |
GO_0043507 | Biological process | positive regulation of JUN kinase activity |
GO_0007254 | Biological process | JNK cascade |
GO_0002726 | Biological process | positive regulation of T cell cytokine production |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0006954 | Biological process | inflammatory response |
GO_0038173 | Biological process | interleukin-17A-mediated signaling pathway |
GO_0000165 | Biological process | MAPK cascade |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_1904754 | Biological process | positive regulation of vascular associated smooth muscle cell migration |
GO_0007249 | Biological process | canonical NF-kappaB signal transduction |
GO_0034138 | Biological process | toll-like receptor 3 signaling pathway |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0043276 | Biological process | anoikis |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0038172 | Biological process | interleukin-33-mediated signaling pathway |
GO_0038095 | Biological process | Fc-epsilon receptor signaling pathway |
GO_0045787 | Biological process | positive regulation of cell cycle |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0006338 | Biological process | chromatin remodeling |
GO_0032743 | Biological process | positive regulation of interleukin-2 production |
GO_0002223 | Biological process | stimulatory C-type lectin receptor signaling pathway |
GO_0051403 | Biological process | stress-activated MAPK cascade |
GO_0006955 | Biological process | immune response |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0007252 | Biological process | I-kappaB phosphorylation |
GO_0016239 | Biological process | positive regulation of macroautophagy |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0042742 | Biological process | defense response to bacterium |
GO_0045793 | Biological process | positive regulation of cell size |
GO_0038066 | Biological process | p38MAPK cascade |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_0002753 | Biological process | cytoplasmic pattern recognition receptor signaling pathway |
GO_0035872 | Biological process | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
GO_1904385 | Biological process | cellular response to angiotensin |
GO_0005886 | Cellular component | plasma membrane |
GO_0005829 | Cellular component | cytosol |
GO_0140672 | Cellular component | ATAC complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0010008 | Cellular component | endosome membrane |
GO_0005634 | Cellular component | nucleus |
GO_0004707 | Molecular function | MAP kinase activity |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0008349 | Molecular function | MAP kinase kinase kinase kinase activity |
GO_1990450 | Molecular function | linear polyubiquitin binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0004709 | Molecular function | MAP kinase kinase kinase activity |
GO_0001223 | Molecular function | transcription coactivator binding |
GO_0120283 | Molecular function | protein serine/threonine kinase binding |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0005114 | Molecular function | type II transforming growth factor beta receptor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
GO_0035173 | Molecular function | histone kinase activity |
Gene name | MAP3K7 |
Protein name | mitogen-activated protein kinase kinase kinase (EC 2.7.11.25) Mitogen-activated protein kinase kinase kinase 7 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) |
Synonyms | TAK1 |
Description | FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway . Plays an important role in the cascades of cellular responses evoked by changes in the environment . Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR) . Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7 . These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs); both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1) . Independently of MAP2Ks and p38 MAPKs, acts as a key activator of NF-kappa-B by promoting activation of the I-kappa-B-kinase (IKK) core complex . Mechanistically, recruited to polyubiquitin chains of RIPK2 and IKBKG/NEMO via TAB2/MAP3K7IP2 and TAB3/MAP3K7IP3, and catalyzes phosphorylation and activation of IKBKB/IKKB component of the IKK complex, leading to NF-kappa-B activation . In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B . Promotes TRIM5 capsid-specific restriction activity . Phosphorylates RIPK1 at 'Ser-321' which positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity). Phosphorylates STING1 in response to cGAMP-activation, promoting association between STEEP1 and STING1 and STING1 translocation to COPII vesicles . . |
Accessions | ENST00000703101.1 ENST00000700583.1 A0A8V8TPV8 A0A8V8TQ28 A0A8V8TQE8 A0A8V8TRC0 O43318 A0A8V8TR14 ENST00000700585.1 A0A8V8TR17 ENST00000369332.7 [O43318-2] A0A8V8TRC6 A0A8V8TPW3 ENST00000700580.1 [O43318-2] ENST00000703100.1 A0A8V8TQF2 ENST00000700582.1 ENST00000700584.1 ENST00000700589.1 ENST00000700581.1 A0A8V8TQF4 ENST00000700591.1 ENST00000700592.1 A0A8V8TRC2 ENST00000369329.8 [O43318-1] A0A8V8TQL7 ENST00000369327.7 [O43318-4] ENST00000700587.1 ENST00000369325.7 [O43318-3] A0A8V8TQF8 ENST00000700593.1 ENST00000700594.1 |